STAT
SEPTEMBER 8, 2023
A diagnosis of ALS has long been seen as a death sentence. But in recent years, progress in the world of ALS research and drug development has come to embody a conundrum with far broader implications: The balance between moving aggressively on promising new cures and guarding against false hope.
PharmaVoice
SEPTEMBER 5, 2023
Leaked data for Roche’s immunotherapy appeared positive, but some experts aren’t convinced it’ll make an impact for cancer patients.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Times
SEPTEMBER 8, 2023
The company will use its AI technology during a sub-study to analyse the effect of lansoprazole - News - PharmaTimes
EMCrit Project
SEPTEMBER 3, 2023
In many countries, pulmonary and critical care are commonly bundled together. Consequently, a single person will often be responsible for both inpatient ICU management as well as inpatient pulmonary consultation. Honestly, I have some doubts about whether this is an ideal system. As both pulmonology and critical care medicine become increasingly complex, it's becoming impossible […] EMCrit Project by Josh Farkas.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
STAT
SEPTEMBER 8, 2023
On a Friday afternoon in July, as many New Yorkers fled the scorching city streets, a couple of dozen out-of-towners descended on Times Square. They came bearing gold letter balloons spelling out LFVN, the stock symbol for LifeVantage, the company they’d come to promote, and foam cutouts of its navy blue supplement bottles. LifeVantage’s chief executive officer, Steve Fife, rang the Nasdaq exchange’s closing bell, a celebration of the Utah-based company’s new products
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Pharma Times
SEPTEMBER 7, 2023
The trial analyses the impact of its ‘Neuro-Cells’ among patients with traumatic spinal cord injuries - News - PharmaTimes
The Pharmacist
SEPTEMBER 7, 2023
The ‘unprecedented challenges’ faced by community pharmacies will be spotlighted at a Westminster debate next week. Conservative MP for Waveney Peter Aldous has secured a debate at Westminster Hall on the afternoon of Thursday 14 September on the ‘future of community pharmacies’. Confirming the news, Community Pharmacy England (CPE) said this provided a ‘very good […] The post Westminster debate to spotlight 'unprecedented challenges' in community pharmacy appeared first on The P
STAT
SEPTEMBER 7, 2023
The organization that runs the infectious diseases surveillance system ProMED terminated at least three of the program’s top moderators on Thursday. The three were leaders of a strike that began in early August — one that is scheduled to end on Monday. Longtime moderators Marjorie Pollack and Maria Jacobs, along with associate editor Leo Liu, received notification from ISID CEO Linda MacKinnon that their consulting agreements with the International Society for Infectious Disea
PharmaVoice
SEPTEMBER 6, 2023
Murray McKinnon, CSO of Empress Therapeutics, believes its drug discovery platform holds the key to treating and detecting many diseases.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharma Times
SEPTEMBER 7, 2023
The treatment targets extensive stage small cell lung cancer and aims to boost therapeutic impact - News - PharmaTimes
The Pharmacist
SEPTEMBER 8, 2023
The Pharmacists’ Defence Association (PDA) has urged pharmacists to ask their employers to sign the Covid-19 safety pledge, which includes a commitment to ensuring that all workers who test positive for the virus are both asked to self-isolate and given adequate support to stay at home. The representative body itself has recently signed the pledge, […] The post Ask employers to sign Covid-19 safety pledge, urges PDA appeared first on The Pharmacist.
STAT
SEPTEMBER 7, 2023
A recent study prompted CNN to report, “Most cancer screenings don’t ultimately give someone extra time beyond their regular lifespan.” Does that mean it’s time to dismantle the cancer screening infrastructure in the United States? Probably not. The complex math behind screening befuddled the researchers’ attempts to assess whether screening helped people live longer, leading to unsupportable conclusions.
PharmaVoice
SEPTEMBER 8, 2023
The PASTEUR Act is likely heading for another legislative blow, but advocates say they see a future for the mechanism to fund the battle against antimicrobial resistance.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Pharma Times
SEPTEMBER 8, 2023
Clinically significant results have emerged from trial evaluating the company’s AMO-02 candidate - News - PharmaTimes
Safe Biologics
SEPTEMBER 6, 2023
On September 6th, AI Arthritis released Episode 88 of its AI Arthritis 360 Talk Show , in which ASBM representatives discuss potential policy changes regarding interchangeable biosimilars and how they may undermine the patient protections currently in place. Joining AI Arthritis Executive Director and host Tiffany Westrich-Robertson were ASBM Executive Director Michael Reilly, ASBM Chairman Ralph McKibbin MD FACP FACG AGAF, and ASBM Steering Committee Member Andrew Spiegel, Executive Director of
STAT
SEPTEMBER 5, 2023
University of California graduate students were thrilled last December when they won what they thought were big pay increases after an unprecedented strike. Most of them could expect a 10% salary increase the first year of the new three-year contract, the university system said. But students contend it hasn’t worked out that way. Graduate students on some of the academic system’s 10 campuses are accusing their universities of wage theft, claiming they’re using sleight of han
PharmaVoice
SEPTEMBER 7, 2023
Armon Sharei took his startup SQZ from a graduate project at MIT to a Big Pharma partnership worth $1B+. Despite the company’s stumbles, Sharei’s enthusiasm for biotech’s future remains.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharma Times
SEPTEMBER 6, 2023
Therapy is used among adult patients with symptomatic obstructive hypertrophic cardiomyopathy - News - PharmaTimes
pharmaphorum
SEPTEMBER 7, 2023
Five takeaways from the CAR-TCR cell therapy conference Mike.
STAT
SEPTEMBER 8, 2023
Heart disease is killing fewer Americans overall, however, cardiovascular deaths where obesity was listed as a key contributing factor have tripled between 1999 and 2020, according to a new study published Wednesday in the Journal of the American Heart Association. And, Black women had the highest mortality rate out of all the population groups studied.
PharmaVoice
SEPTEMBER 7, 2023
Biogen, Sanofi, Bristol Myers Squibb and more have all recently announced major executive changes.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Pharma Times
SEPTEMBER 6, 2023
Technology combines AI-based, ultrasound-guided 3D reconstruction with robotic needle insertion - News - PharmaTimes
BioPharma Dive
SEPTEMBER 5, 2023
The FDA-approved therapy, called Palforzia, was little used, leading Nestle to abandon a business it had secured in a $2.6 billion deal three years ago.
STAT
SEPTEMBER 7, 2023
Ever since Medicare was given power to negotiate prices for certain medicines, the pharmaceutical industry has argued the move will end badly for patients. Beyond complaining about price controls and unconstitutional mandates, the key message aimed at the American public has been that innovation will suffer. This is a familiar but tiring refrain.
pharmaphorum
SEPTEMBER 8, 2023
Combining new and existing immunity: A 3D approach to killing cancer Mike.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Pharma Times
SEPTEMBER 5, 2023
Candidate ESO-101 will treat participating patients across five European countries - News - PharmaTimes
Pharmaceutical Technology
SEPTEMBER 5, 2023
Nestlé has sold its peanut allergy drug Palforzia to Swiss biopharma Stallergenes Greer harma, concluding a year-long strategic review.
STAT
SEPTEMBER 5, 2023
More and more people, especially early career workers , want jobs fighting climate change. But when we think about climate work, we tend to imagine only a small number of activities, like integrating renewables into the grid or planning cities to be resilient against flooding and fires. We often overlook jobs in another key climate technology sector: biotechnology.
Expert insights. Personalized for you.
363 
Let's personalize your content